Food and Drug Administration: Guanxin Suhe Pills produced by Anguo Pharmaceutical failed the sampling inspection
-
Last Update: 2014-01-06
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Recently, the State Food and Drug Administration issued the 4th drug quality announcement in 2013 In the list of drugs that are not up to the standard in the random inspection during the operation and use, Guanxinsuhe pill (production batch number: 116603, 116604, 116606) produced by Hebei Anguo Pharmaceutical Group Co., Ltd was included The sampling varieties involved in this announcement include 23 national essential drug varieties such as Tianwang Buxin pill, 10 other preparation varieties such as maibaimycin tablet, and 1 Chinese medicine variety artificial bezoar / in vitro cultivation bezoar, with a total of 4072 batches of samples Among them, all the inspection items of 4033 batches of samples meet the requirements of the standard, with a qualified rate of 99.04%; some of the other 39 batches of samples do not meet the requirements of the standard The non-conforming items mainly include content determination items, identification items, disintegration time limit, solubility, microbial limit, release degree, etc The State Food and drug administration has ordered the relevant provincial (District, city) food and drug administrations to investigate and deal with the drugs and relevant units that have been verified to be not in conformity with the standard through sampling inspection.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
